Stämm
PrivateLast Round
Series A
Mar 1, 2022
Total Funding Raised
$19.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Stämm operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series A round in March 2022.
Stämm is a biotechnology company that develops advanced biomanufacturing solutions, specializing in automated, continuous production processes for biologics, cell therapies, and emerging applications using microfluidics and 3D printing technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Clean Manufacturing, 3D Printing
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stämm Comparables
Compare Stämm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Astraveus | 82% | |
| Ori Biotech | 81% | |
| MFX | 80% |
For institutional investors. Book with your work email.
Stämm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 1, 2022 | ||||
| Seed | Jun 27, 2019 | ||||
| Accelerator | Sep 20, 2018 | ||||
| Accelerator | Jul 25, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Stämm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| VX Ventures | Series A |
| GRIDX | Series A |
| Varana Capital | Series A |
| Teramips Technologies | Series A |
| IndieBio | Accelerator |
| Draper Associates | Series A, Seed |
| Draper Cygnus | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 445% MoM, reaching 4.3K.
- Mar 12, 2026
Launched the High-Throughput Bioprocessor (HTB) for biomanufacturing.
For institutional investors. Book with your work email.
Stämm Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Stämm's valuation, stock price, and market status.
Is Stämm a public or private company?
Stämm is a private company.
What is the current stock price of Stämm?
Stämm is a private company, so its shares have no public market price. Caplight tracks Stämm's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Stämm worth (valuation)?
Valuation information for Stämm is not publicly available.
Can I buy Stämm stock?
Stämm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Stämm's last funding round?
Stämm's most recent funding round was Series A on March 1, 2022.
Who are the main investors in Stämm?
Key investors in Stämm include Varana Capital, IndieBio, Draper Associates.
Will Stämm IPO soon?
No public IPO plans have been announced for Stämm.
How can I track Stämm secondary market activity?
Caplight tracks bids, offers, and trades in Stämm's shares on secondary markets.